DE60012044D1 - Imidazopyridinderivate als liganden für gaba-rezeptoren - Google Patents
Imidazopyridinderivate als liganden für gaba-rezeptorenInfo
- Publication number
- DE60012044D1 DE60012044D1 DE60012044T DE60012044T DE60012044D1 DE 60012044 D1 DE60012044 D1 DE 60012044D1 DE 60012044 T DE60012044 T DE 60012044T DE 60012044 T DE60012044 T DE 60012044T DE 60012044 D1 DE60012044 D1 DE 60012044D1
- Authority
- DE
- Germany
- Prior art keywords
- ligands
- derivatives
- imidazopyride
- gaba receptors
- phenylimidazo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- 102000005915 GABA Receptors Human genes 0.000 title 1
- 108010005551 GABA Receptors Proteins 0.000 title 1
- AFWDAKKJDBULCR-UHFFFAOYSA-N 3-phenylimidazo[1,2-a]pyridine Chemical class C=1N=C2C=CC=CN2C=1C1=CC=CC=C1 AFWDAKKJDBULCR-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 102000027484 GABAA receptors Human genes 0.000 abstract 1
- 108091008681 GABAA receptors Proteins 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927687.5A GB9927687D0 (en) | 1999-11-23 | 1999-11-23 | Therapeutic agents |
GB9927687 | 1999-11-23 | ||
PCT/GB2000/004451 WO2001038326A2 (en) | 1999-11-23 | 2000-11-22 | Imidazo-pyridine derivatives as ligands for gaba receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60012044D1 true DE60012044D1 (de) | 2004-08-12 |
DE60012044T2 DE60012044T2 (de) | 2005-07-07 |
Family
ID=10865000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60012044T Expired - Fee Related DE60012044T2 (de) | 1999-11-23 | 2000-11-22 | Imidazopyridinderivate als liganden für gaba-rezeptoren |
Country Status (10)
Country | Link |
---|---|
US (1) | US6872731B2 (de) |
EP (1) | EP1235827B1 (de) |
JP (1) | JP2003514907A (de) |
AT (1) | ATE270672T1 (de) |
AU (1) | AU780081B2 (de) |
CA (1) | CA2392327A1 (de) |
DE (1) | DE60012044T2 (de) |
ES (1) | ES2223614T3 (de) |
GB (1) | GB9927687D0 (de) |
WO (1) | WO2001038326A2 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6908929B2 (en) * | 2000-03-31 | 2005-06-21 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituted imidazopyridines |
EP1277754B8 (de) * | 2000-04-27 | 2005-09-28 | Astellas Pharma Inc. | Imidazopyridin-derivate |
GB0117277D0 (en) | 2001-07-16 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
GB0117060D0 (en) | 2001-07-12 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
DE60318198T2 (de) * | 2002-05-02 | 2008-12-04 | Merck & Co., Inc. | Tyrosinkinase-hemmer |
GB0212048D0 (en) * | 2002-05-24 | 2002-07-03 | Merck Sharp & Dohme | Therapeutic agents |
GB0212049D0 (en) | 2002-05-24 | 2002-07-03 | Merck Sharp & Dohme | Therapeutic agents |
DE10247271A1 (de) * | 2002-10-10 | 2004-08-26 | Grünenthal GmbH | Substituierte C-Imidazo[1,2-a]pyridin-3-yle |
WO2004076452A1 (en) * | 2003-02-26 | 2004-09-10 | Merck Sharp & Dohme Limited | 5,8-DIFLUOROIMIDAZO[1,2-a]PYRIDINES AS GABA-A α2/α3 LIGANDS FOR TREATING ANXIETY AND/OR DEPRESSION |
WO2005019238A1 (ja) | 2003-08-22 | 2005-03-03 | Meiji Seika Kaisha, Ltd. | 新規アザライド及びアザラクタム誘導体とその製造法 |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
CA2625153A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
US20070112017A1 (en) * | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
WO2007073283A1 (en) | 2005-12-20 | 2007-06-28 | Astrazeneca Ab | Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
US7465795B2 (en) | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (de) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenese mittels Angiotensin-Modulation |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
WO2008030651A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
WO2008078100A2 (en) | 2006-12-22 | 2008-07-03 | Astex Therapeutics Limited | Tricyclic amine derivatives as protein tyrosine kinase inhibitors |
CN101679408B (zh) | 2006-12-22 | 2016-04-27 | Astex治疗学有限公司 | 作为fgfr抑制剂的双环杂环化合物 |
GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
MX2010004244A (es) | 2007-10-17 | 2010-04-30 | Novartis Ag | Derivados de imidazo [i,2-a]-piridina utiles como inhibidores de cinasa tipo activina (alk). |
CA2710452A1 (en) * | 2007-12-21 | 2009-07-09 | Wyeth Llc | Imidazo [1,2-a] pyridine compounds |
GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
AU2010226490A1 (en) | 2009-03-20 | 2011-10-06 | Amgen Inc. | Inhibitors of PI3 kinase |
GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
JP6430383B2 (ja) | 2012-09-28 | 2018-11-28 | ヴァンダービルト ユニバーシティーVanderbilt University | 選択的bmp阻害剤としての縮合複素環化合物 |
WO2015044095A1 (en) * | 2013-09-26 | 2015-04-02 | F. Hoffmann-La Roche Ag | Imidazo[1,2-a]pyridin-7-amines as imaging tools |
CN105175325B (zh) * | 2015-10-21 | 2017-10-10 | 济南诚汇双达化工有限公司 | 一种4‑氯‑2‑吡啶甲酸甲酯的制备方法 |
US10745400B2 (en) | 2018-03-14 | 2020-08-18 | Vanderbuilt University | Inhibition of BMP signaling, compounds, compositions and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9801234D0 (en) * | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801397D0 (en) * | 1998-01-22 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
AU2001270297A1 (en) | 2000-06-30 | 2002-01-14 | Neurogen Corporation | 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands |
-
1999
- 1999-11-23 GB GBGB9927687.5A patent/GB9927687D0/en not_active Ceased
-
2000
- 2000-11-22 AT AT00977693T patent/ATE270672T1/de not_active IP Right Cessation
- 2000-11-22 AU AU15331/01A patent/AU780081B2/en not_active Ceased
- 2000-11-22 EP EP00977693A patent/EP1235827B1/de not_active Expired - Lifetime
- 2000-11-22 DE DE60012044T patent/DE60012044T2/de not_active Expired - Fee Related
- 2000-11-22 WO PCT/GB2000/004451 patent/WO2001038326A2/en active IP Right Grant
- 2000-11-22 JP JP2001540089A patent/JP2003514907A/ja not_active Withdrawn
- 2000-11-22 ES ES00977693T patent/ES2223614T3/es not_active Expired - Lifetime
- 2000-11-22 CA CA002392327A patent/CA2392327A1/en not_active Abandoned
-
2002
- 2002-05-23 US US10/155,691 patent/US6872731B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1235827B1 (de) | 2004-07-07 |
DE60012044T2 (de) | 2005-07-07 |
AU1533101A (en) | 2001-06-04 |
AU780081B2 (en) | 2005-02-24 |
CA2392327A1 (en) | 2001-05-31 |
JP2003514907A (ja) | 2003-04-22 |
ATE270672T1 (de) | 2004-07-15 |
US6872731B2 (en) | 2005-03-29 |
GB9927687D0 (en) | 2000-01-19 |
WO2001038326A2 (en) | 2001-05-31 |
US20020188000A1 (en) | 2002-12-12 |
EP1235827A2 (de) | 2002-09-04 |
ES2223614T3 (es) | 2005-03-01 |
WO2001038326A3 (en) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60012044D1 (de) | Imidazopyridinderivate als liganden für gaba-rezeptoren | |
DE60304572D1 (de) | Imidazopyridin derivate als liganden für gaba rezeptoren | |
DE60115282D1 (de) | Imidazotriazin-derivate als liganden für gaba-rezeptoren | |
ATE310002T1 (de) | Imidazotriazin-derivate als gaba-rezeptor- liganden | |
BG108166A (en) | Imidazo-pyrimidine derivatives as liigands for gaba receptors | |
DE69936998D1 (de) | Pyrazolotriazinderivate als gaba-rezeptorliganden | |
DE60214532D1 (de) | Imidazopyrimidin-derivate als liganden für gaba-rezeptoren | |
DE60016566D1 (de) | Triazolopyridazinderivate als liganden für gaba-rezeptoren | |
DE60307462D1 (de) | 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren | |
NO990304L (no) | Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer | |
DE60006835D1 (de) | Imidazopyridinderivate als gaba rezeptor liganden | |
DE60006260D1 (de) | Imidazotriazinderivate als gaba rezeptor-liganden | |
ATE250062T1 (de) | Triazolopiridazinederivate als gaba rezeptor- liganden | |
BG104671A (en) | Triazolo-pyridazine derivatives as ligands for gaba receptors | |
CA2207784A1 (en) | Certain pyrrolopyridine derivatives; novel crf1 specific ligands | |
ATE420867T1 (de) | Phenylpyridazin derivative als liganden für gaba- rezeptoren | |
JO2312B1 (en) | Imidazo-pyrimidine derivatives as associative groups of JABA receptors | |
PE44299A1 (es) | Derivados sustituidos de triazolo-piridacina como ligandos para receptores gaba |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |